Developing New Anti-Arrhythmics: Clues from the Molecular Basis of Cardiac Ryanodine Receptor (RyR2) Ca2+-Release Channel Dysfunction

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|13|31|3195-3211

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.13, Iss.31, 2007-11, pp. : 3195-3211

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antiarrhythmic Potential of Drugs Targeting the Cardiac Ryanodine Receptor Ca2+ Release Channel: Case Study of Dantrolene

By  

Current Pharmaceutical Design, Vol. 21, Iss. 8, 2015-01 ,pp. : 1062-1072

Bentham Science Publishers

Access to resources Recommend Favorite

2-Hydroxycarbazole induces Ca 2+ release from sarcoplasmic reticulum by activating the ryanodine receptor

By Tovey S.C.   Longland C.L.   Mezna M.   Michelangeli F.  

European Journal of Pharmacology, Vol. 354, Iss. 2, 1998-08 ,pp. : 245-251

Elsevier

Access to resources Recommend Favorite

Cyclic ADP-ribose, the ryanodine receptor and Ca 2+ release

By Sitsapesan R.   McGarry S.J.   Williams A.J.  

Trends in Pharmacological Sciences, Vol. 16, Iss. 11, 1995-11 ,pp. : 386-391

Elsevier

Access to resources Recommend Favorite

Modulating Ca2+ release by the IP3R/Ca2+ channel as a potential therapeutic treatment for neurological diseases

By Chan Carmen CM  

Pharmaceutical Patent Analyst, Vol. 2, Iss. 5, 2013-09 ,pp. : 629-636

Future Science

Access to resources Recommend Favorite

9-Methyl-7-bromoeudistomin D induces Ca 2+ release from cardiac sarcoplasmic reticulum

By Seino-Umeda A.   Fang Y.-I.   Ishibashi M.   Kobayashi J.   Ohizumi Y.  

European Journal of Pharmacology, Vol. 357, Iss. 2, 1998-09 ,pp. : 261-265

Elsevier

Access to resources Recommend Favorite